Healthcare -
Biotechnology - NASDAQ - US
$ 0.3911
-0.19 %
$ 48.7 M
Market Cap
-0.62
P/E
MRSN - NET INCOME
Net Income MRSN - Mersana Therapeutics, Inc.
-69.2 M
LAST VALUE
41.79%
2 YEAR CAGR
-19.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR